Evidence map›Paper›PMID 19846544›Full record

Trial reportThe American journal of clinical nutrition2009

Effect of a dietary intervention and n-3 fatty acid supplementation on measures of serum lipid and insulin sensitivity in persons with HIV.

Margo N Woods, Christine A Wanke, Pei-Ra Ling, Kristy M Hendricks, Alice M Tang, Tamsin A Knox, Charlotte E Andersson, Kimberly R Dong, Sally C Skinner, Bruce R Bistrian

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 4 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 4 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Observational
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Margo N WoodsDepartment of Public Health and Community Medicine, Nutrition/Infection Unit, Tufts University School of Medicine, Boston, MA, USA.
Christine A Wanke
Pei-Ra Ling
Kristy M Hendricks
Alice M Tang
Tamsin A Knox
Charlotte E Andersson
Kimberly R Dong
Sally C Skinner
Bruce R Bistrian
Tufts University · US

Funding

ZIDOVUDINE &LAMIVUDINE ALONE OR IN COMBINATION ON BODY COMPOSITIONM01RR000054 · NCRR · TUFTS MEDICAL CENTER · PI MENON, VANDANA · 1985 to 2005
$12.2M
Nutrition and Metabolism CoreP30DA013868 · NIDA · TUFTS UNIVERSITY BOSTON · PI GORBACH, SHERWOOD · 2002 to 2012
$10.0M
Nutrition Intervention: Metabolic Complications of HIV+R01DK063619 · NIDDK · TUFTS UNIVERSITY BOSTON · PI WOODS, MARGO N · 2002 to 2006
$1.4M
NCRR NIH HHS M01-RR00054NIDA NIH HHS P30 DA013868NIDDK NIH HHS R01 DK063619NIDDK NIH HHS R01 DK63619PHS HHS P01-D45734
6 · The paper itself

Abstract

backgroundElevated serum triglyceride and low HDL-cholesterol concentrations have been reported in persons with HIV.

objectiveThe effect of a dietary intervention plus n-3 (omega-3) fatty acid supplementation on serum triglycerides and markers of insulin sensitivity was investigated.

designFifty-four persons with HIV and elevated serum triglycerides (>150 mg/dL) and/or abnormal Quantitative Insulin Sensitivity Check Index values (<0.35 but >0.30) were recruited for a dietary intervention in which total fat, type of fat, fiber, and glycemic load were controlled along with supplementation with n-3 fatty acids to achieve an intake of 6 g/d. The subjects were randomly assigned to an intervention or control group, and serum lipids, markers of insulin sensitivity, and serum phospholipid fatty acids were measured in both groups at baseline, 3 wk, and 13 wk.

resultsTriglycerides in the intervention group decreased from a median of 180 mg/dL (interquartile range: 141, 396) to 114 mg/dL (interquartile range: 84, 169) from baseline to 3 wk, whereas they remained stable in the control group (P = 0.003). Serum phospholipid fatty acids indicated a decrease in de novo lipogenesis and a decrease in arachidonic acid (% nmol; P <or= 0.001) in the intervention group. At 3 wk, the insulin area under the curve decreased but not significantly.

conclusionsDiet and n-3 fatty acid supplementation dramatically reduced serum triglycerides, decreased arachidonic acid in the phospholipids fraction, and appeared to decrease the de novo lipogenesis associated with the metabolic syndrome in the intervention group.

Indexed as

AdultArachidonic AcidArea Under CurveBody Mass IndexCholesterol, HDLDietary SupplementsFatty Acids, Omega-3FemaleHIV InfectionsHumansInsulin ResistanceMaleMiddle AgedPhospholipidsTriglyceridesArachidonic AcidCholesterol, HDLFatty Acids, Omega-3PhospholipidsTriglycerides

Identifiers

PMID19846544
PMCPMC2777468
OpenAlexW2122066019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.